Use of ezetimibe during HIV infection.

1. Mammeri H, Eb F, Berkani A et al. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J Antimicrob Chemother 2008; 61: 498–503. 2. Nordmann P, Mammeri H. Extended-spectrum cephalosporinases: structure, detection, and epidemiology. Future Microbiol 2007; 2: 297–307. 3. Mammeri H, Poirel L, Nordmann P. Extension of the hydrolysis spectrum of AmpC b-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J Antimicrob Chemother 2007; 60: 490–4. 4. Mammeri H, Nordmann P, Berkani A et al. Contribution of extended-spectrum AmpC (ESAC) b-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol Lett 2008; 282: 238–40. 5. Mammeri H, Poirel L, Fortineau N et al. Naturally occurring extended-spectrum cephalosporinases in Escherichia coli. Antimicrob Agents Chemother 2006; 50: 2573–6. 6. Chanal C, Poupart MC, Sirot D et al. Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 b-lactamase genes. Antimicrob Agents Chemother 1992; 36: 1817–20.